MilliporeSigma breaks ground on new production facility

LabPulse.com staff writers
Jul 18, 2022
2022 07 19 20 10 5067 Manufacturing Facility Process 400

MilliporeSigma has broken ground on a new production facility for its Hi-Flow Plus lateral flow membrane technology used in rapid COVID-19 tests.

Made possible by a $136.7 million award from the U.S. Department of Defense on behalf of the U.S. Department of Health and Human Services, the new facility in Sheboygan, WI, will be MilliporeSigma's first site in the U.S. that's capable of producing diagnostic-grade membrane, according to the company.

Latest in Infectious
Mycobacterium Tuberculosis Bacteria Niaid Social
Researchers tweak TB treatment assay to support global use
April 10, 2024
Sepsis Bacteria Social
Researchers map protein biomarkers in sepsis fight
April 2, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Licensed under Creative Commons
Harvard team develops compound to combat drug-resistant bacteria
March 13, 2024
Related Stories
2021 05 26 16 06 9500 Global Collaboration Business 400
Research and Development
MilliporeSigma closes Exelead buy for lipid nanoparticle boost
2021 05 26 16 06 9500 Global Collaboration Business 400
Infectious
MilliporeSigma announces corporate reorganization
2021 02 18 23 32 2083 Pharmaceutical Manufacturing Scientists 400
Influenza
MilliporeSigma secures $137M contract from U.S. government
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Infectious
Researchers tweak TB treatment assay to support global use
By Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
Mycobacterium Tuberculosis Bacteria Niaid Social
Researchers map protein biomarkers in sepsis fight
By Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Sepsis Bacteria Social
WHO launches new guidance on TB diagnostics
By LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
Bacteria Mycobacterium Tuberculosis Social
Harvard team develops compound to combat drug-resistant bacteria
By Matt Limb
Harvard University researchers say they have created an antibiotic that can overcome many drug-resistant infections.
March 13, 2024
Licensed under Creative Commons
New class of broad-spectrum antivirals could be first line of pandemic defense: Study
By Nick Paul Taylor
Targeting a cellular pathway has inhibited SARS-CoV-2 and other RNA viruses in preclinical tests, pointing to a potential new class of first-line antivirals with broad effectiveness against emerging pathogens.
March 5, 2024
Lab Virus Bacteria Research Social
BioMérieux, FDA to collaborate on combating food-borne pathogens
By LabPulse.com staff writers
BioMérieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Bacteria Microscope Social
Global research network launches to fight strep A infections
By Matt Limb
Scientists have launched a global research network to combat deadly strep A infections that can trigger sepsis and heart damage in children.
February 27, 2024
Licensed under Creative Commons
Bavarian Nordic ends cancer vaccine program
By LabPulse.com staff writers
Biotech firm Bavarian Nordic is ceasing all work on its cancer vaccine program, instead prioritizing its infectious disease projects.
February 22, 2024
Vial Vaccine Vial Tech Social
CRISPR and nanopore technology enable sensitive and specific mpox detection
By Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in Biosensors and Bioelectronics.
February 16, 2024
3 D Monkeypox Infecting Cell Social
T2 Biosystems gets FDA nod to expand bacteria panel
By LabPulse.com staff writers
T2 Biosystems announced it received 510(k) clearance to add A. baumannii to its T2Bacteria Panel.
February 12, 2024
Fda Button Social
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
By LabPulse.com staff writers
CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect Neisseria gonorrhoeae, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.
February 8, 2024
Bacteria Neisseria Gonorrhoeae Social
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
Antigen Tcell Cytokines Social
Page 1 of 150
Next Page